The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
IL-1 receptor 2 (IL-1R2) and its role in immune regulation
Open accessAbstract
The cytokine IL-1 is critical to the pathogenesis of a variety of human conditions and diseases. Unlike most other cytokines, IL-1 is counterbalanced by two endogenous inhibitors. The functional significance of IL-1 receptor antagonist (IL-1RA) is well documented due to the clinical utilization of the recombinant human IL-1RA analog, anakinra. In contrast, much less is known about the type 2 IL-1 receptor (IL-1R2), which acts as a decoy receptor for IL-1. While IL-1R2 is structurally similar to the type 1 IL-1 receptor (IL-1R1) responsible for IL-1 signal transduction, its truncated cytoplasmic domain and lack of Toll-IL-1 receptor (TIR) region renders IL-1R2 incapable of transmembrane signaling. IL-1R2 competes with IL-1R1 for ligands and for the IL-1R1 co-receptor, IL-1 receptor accessory protein (IL-1RAP). Additionally, IL-1R2 exists in both a membrane bound and soluble form (sIL-1R2) that has biological properties similar to both a decoy receptor and a binding protein. Thus far, IL-1R2 has been implicated in arthritis, endometriosis, organ transplantation, sepsis/sickness behavior, diabetes, atherosclerosis, autoimmune inner ear disease (AIED), Alzheimer’s disease and ulcerative colitis. In this review, we will detail the functional properties of IL-1R2 and examine its role in human disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Unravelling the pathogenesis of inflammatory bowel disease
Xavier, R. J., & Podolsky, D. K. (2007) · Nature · doi:10.1038/nature06005 · Cited by 4,364
Type 2 diabetes as an inflammatory disease
Donath, M. Y., & Shoelson, S. E. (2011) · Nature Reviews Immunology · doi:10.1038/nri2925 · Cited by 3,737
Immunological and inflammatory functions of the interleukin-1 family
Dinarello, C. A. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.021908.132612 · Cited by 3,466
Chen, H., Charlat, O., Tartaglia, L. A., Woolf, E. A., Weng, X., Ellis, S. J., Lakey, N. D., Culpepper, J., More, K. J., Breitbart, R. E., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81294-5 · Cited by 2,214
Treating inflammation by blocking interleukin-1 in a broad spectrum of diseases
Dinarello, C. A., Simon, A., & van der Meer, J. W. M. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3800 · Cited by 1,768
Anderson, C. A., Boucher, G., Lees, C. W., Franke, A., D'Amato, M., Taylor, K. D., Lee, J. C., Goyette, P., Imielinski, M., Latiano, A., et al. (2011) · Nature Genetics · doi:10.1038/ng.764 · Cited by 1,320
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S. K., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 980
Weber, A., Wasiliew, P., & Kracht, M. (2010) · Science Signaling · doi:10.1126/scisignal.3105cm1 · Cited by 962
IL-1 pathways in inflammation and human diseases
Gabay, C., Lamacchia, C., & Palmer, G. (2010) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2010.4 · Cited by 897
cDNA Expression Cloning of the IL-1 Receptor, a Member of the Immunoglobulin Superfamily
Sims, J. E., March, C. J., Cosman, D., Widmer, M. B., MacDonald, H. R., McMahan, C. J., Grubin, C. E., Wignall, J. M., Jackson, J. L., Call, S. M., et al. (1988) · Science · doi:10.1126/science.2969618 · Cited by 889
Structural basis for signal transduction by the Toll/interleukin-1 receptor domains
Xu, Y., Tao, X., Shen, B., Horng, T., Medzhitov, R., Manley, J. L., & Tong, L. (2000) · Nature · doi:10.1038/35040600 · Cited by 818
Cytokine‐Induced Sickness Behavior: Mechanisms and Implications
Dantzer, R. (2001) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2001.tb05827.x · Cited by 801
The role of inflammation in Alzheimer’s disease
Tuppo, E. E., & Arias, H. R. (2005) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2004.07.009 · Cited by 734
Dunne, A., & O'Neill, L. A. J. (2003) · Science's STKE · doi:10.1126/stke.2003.171.re3 · Cited by 711
A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types.
McMahan, C. J., Slack, J. L., Mosley, B., Cosman, D., Lupton, S. D., Brunton, L. L., Grubin, C. E., Wignall, J. M., Jenkins, N. A., & Brannan, C. I. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb07831.x · Cited by 677
Molecular Cloning and Characterization of a Second Subunit of the Interleukin 1 Receptor Complex
Greenfeder, S. A., Nunes, P., Kwee, L., Labow, M., Chizzonite, R. A., & Ju, G. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.23.13757 · Cited by 639
Interleukin 1 signaling occurs exclusively via the type I receptor.
Sims, J. E., Gayle, M. A., Slack, J. L., Alderson, M. R., Bird, T. A., Giri, J. G., Colotta, F., Re, F., Mantovani, A., & Shanebeck, K. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.13.6155 · Cited by 611
The smallest known non-avian theropod dinosaur
Xu, X., Zhou, Z., & Wang, X. (2000) · Nature · doi:10.1038/35047056 · Cited by 539
Macrophage Diversity and Polarization in Atherosclerosis: A Question of Balance
Mantovani, A., Garlanda, C., & Locati, M. (2009) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.108.180497 · Cited by 426
Detection and characterization of high affinity plasma membrane receptors for human interleukin 1.
Dower, S. K., Kronheim, S. R., March, C. J., Conlon, P. J., Hopp, T. P., Gillis, S., & Urdal, D. L. (1985) · The Journal of experimental medicine · doi:10.1084/jem.162.2.501 · Cited by 392
Decoy receptors: a strategy to regulate inflammatory cytokines and chemokines
Mantovani, A., Locati, M., Vecchi, A., Sozzani, S., & Allavena, P. (2001) · Trends in Immunology · doi:10.1016/s1471-4906(01)01941-x · Cited by 383
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Economides, A. N., Carpenter, L. R., Rudge, J. S., Wong, V., Koehler-Stec, E. M., Hartnett, C., Pyles, E. A., Xu, X., Daly, T. J., Young, M. R., et al. (2003) · Nature Medicine · doi:10.1038/nm811 · Cited by 359
Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.
Kent, S., Bluthe, R. M., Dantzer, R., Hardwick, A. J., Kelley, K. W., Rothwell, N. J., & Vannice, J. L. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9117 · Cited by 322
Slack, J. L., Schooley, K., Bonnert, T. P., Mitcham, J. L., Qwarnstrom, E. E., Sims, J. E., & Dower, S. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.4670 · Cited by 315
The immune system and memory consolidation: a role for the cytokine IL-1β
Rachal Pugh, C., Fleshner, M., Watkins, L. R., Maier, S. F., & Rudy, J. W. (2001) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(00)00048-8 · Cited by 314
Effects of interleukin-1 receptor antagonist on the behavioral effects of lipopolysaccharide in rat
Bluthe´, R.-M., Dantzer, R., & Kelley, K. W. (1992) · Brain Research · doi:10.1016/0006-8993(92)90779-9 · Cited by 301
RIVIER, C., CHIZZONITE, R., & VALE, W. (1989) · Endocrinology · doi:10.1210/endo-125-6-2800 · Cited by 271
Leptin modulates β cell expression of IL-1 receptor antagonist and release of IL-1β in human islets
Maedler, K., Sergeev, P., Ehses, J. A., Mathe, Z., Bosco, D., Berney, T., Dayer, J.-M., Reinecke, M., Halban, P. A., & Donath, M. Y. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0305683101 · Cited by 249
Endogenous brain IL-1 mediates LPS-induced anorexia and hypothalamic cytokine expression
Layé, S., Gheusi, G., Cremona, S., Combe, C., Kelley, K., Dantzer, R., & Parnet, P. (2000) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.2000.279.1.r93 · Cited by 243
Arend, W. P., Malyak, M., Smith, M. F., Whisenand, T. D., Slack, J. L., Sims, J. E., Giri, J. G., & Dower, S. K. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.10.4766 · Cited by 241
Taketani, Y., Kuo, T.-M., & Mizuno, M. (1992) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(11)91672-x · Cited by 241
Symons, J. A., Young, P. R., & Duff, G. W. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.5.1714 · Cited by 227
Interleukin 1 signaling occurs exclusively via the typeI receptor
John, E. (1993) · Medical Entomology and Zoology · Cited by 227
Elhage, R., Maret, A., Pieraggi, M.-T., Thiers, J. C., Arnal, J. F., & Bayard, F. (1998) · Circulation · doi:10.1161/01.cir.97.3.242 · Cited by 209
Interleukins in Atherosclerosis: Molecular Pathways and Therapeutic Potential
Von der Thüsen, J. H., Kuiper, J., Van Berkel, T. J. C., & Biessen, E. A. L. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.1.5 · Cited by 207
Re, F., Muzio, M., De Rossi, M., Polentarutti, N., Giri, J. G., Mantovani, A., & Colotta, F. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.2.739 · Cited by 184
Smith, D. E., Hanna, R., Friend, D., Moore, H., Chen, H., Farese, A. M., MacVittie, T. J., Virca, G. D., & Sims, J. E. (2003) · Immunity · doi:10.1016/s1074-7613(02)00514-9 · Cited by 182
Review: Pathophysiology and treatment of bacterial meningitis
Hoffman, O., & Weber, J. R. (2009) · Therapeutic Advances in Neurological Disorders · doi:10.1177/1756285609337975 · Cited by 179
Cui, X., Rouhani, F. N., Hawari, F., & Levine, S. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.12.6814 · Cited by 177
A critical role for interleukin‐1 receptor accessory protein in interleukin‐1 signaling
Korherr, C., Hofmeister, R., Wesche, H., & Falk, W. (1997) · European Journal of Immunology · doi:10.1002/eji.1830270139 · Cited by 175
Zeisel, A., Köstler, W. J., Molotski, N., Tsai, J. M., Krauthgamer, R., Jacob‐Hirsch, J., Rechavi, G., Soen, Y., Jung, S., Yarden, Y., et al. (2011) · Molecular Systems Biology · doi:10.1038/msb.2011.62 · Cited by 169
Lang, D., Knop, J., Wesche, H., Raffetseder, U., Kurrle, R., Boraschi, D., & Martin, M. U. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.12.6871 · Cited by 168
Pruitt, J. H., Copeland, E. M., & Moldawer, L. L. (1995) · Shock · doi:10.1097/00024382-199504000-00001 · Cited by 165
Giri, J. G., Wells, J., Dower, S., McCall, C. E., Guzman, R. N., Slack, J. L., Bird, T. A., Shanebeck, K. D., Grabstein, K. H., Sims, J. E., et al. (1994) · The Journal of Immunology · doi:10.4049/jimmunol.153.12.5802 · Cited by 148
Blocking interleukin-1β in acute and chronic autoinflammatory diseases
Dinarello, C. A. (2010) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2010.02313.x · Cited by 146
Kredel, L. I., Batra, A., Stroh, T., Kühl, A. A., Zeitz, M., Erben, U., & Siegmund, B. (2012) · Gut · doi:10.1136/gutjnl-2011-301424 · Cited by 131
New considerations for the pathogenesis of endometriosis
Gazvani, R., & Templeton, A. (2002) · International Journal of Gynecology & Obstetrics · doi:10.1016/s0020-7292(01)00577-x · Cited by 128
Jensen, L. E., Muzio, M., Mantovani, A., & Whitehead, A. S. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.10.5277 · Cited by 114
Role of Metalloproteases in the Release of the IL-1 type II Decoy Receptor
Orlando, S., Sironi, M., Bianchi, G., Drummond, A. H., Boraschi, D., Yabes, D., & Mantovani, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.50.31764 · Cited by 114
Regulated expression and release of the IL-1 decoy receptor in human mononuclear phagocytes
Colotta, F., Saccani, S., Giri, J. G., Dower, S., Sims, J. E., Introna, M., & Mantovani, A. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.7.2534 · Cited by 108
Dale, M., & Nicklin, M. J. H. (1999) · Genomics · doi:10.1006/geno.1999.5767 · Cited by 106
Rauschmayr, T., Groves, R. W., & Kupper, T. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5814 · Cited by 99
van Deuren, M., van der Ven‐Jongekrijg, J., Vannier, E. G., van Dalen, R., Pesman, G. J., Bartelink, A. K. M., Dinarello, C. A., & van der Meer, J. W. M. (1997) · Blood · doi:10.1182/blood.v90.3.1101 · Cited by 95
Garlind, A., Brauner, A., Höjeberg, B., Basun, H., & Schultzberg, M. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01092-6 · Cited by 87
Fasting Induces an Anti‐Inflammatory Effect on the Neuroimmune System Which a High‐Fat Diet Prevents
Lavin, D. N., Joesting, J. J., Chiu, G. S., Moon, M. L., Meng, J., Dilger, R. N., & Freund, G. G. (2011) · Obesity · doi:10.1038/oby.2011.73 · Cited by 87
Self-citationIncreased serum concentrations of interleukin-1 beta in patients with coronary artery disease.
Hasdai, D., Scheinowitz, M., Leibovitz, E., Sclarovsky, S., Eldar, M., & Barak, V. (1996) · Heart · doi:10.1136/hrt.76.1.24 · Cited by 87
Colotta, F., Re, F., Muzio, M., Polentarutti, N., Minty, A. J., Caput, D., Ferrara, P., & Mantovani, A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)99886-8 · Cited by 86
IL-1β-Mediated Innate Immunity Is Amplified in the db/db Mouse Model of Type 2 Diabetes
O’Connor, J. C., Satpathy, A., Hartman, M. E., Horvath, E. M., Kelley, K. W., Dantzer, R., Johnson, R. W., & Freund, G. G. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.8.4991 · Cited by 86
Self-citationInterleukin‐1 receptor accessory protein interacts with the type II interleukin‐1 receptor
Malinowsky, D., Lundkvist, J., Layé, S., & Bartfai, T. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)00467-0 · Cited by 79
Kalliolias, G. D., Gordon, R. A., & Ivashkiv, L. B. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1001290 · Cited by 78
Kondera‐Anasz, Z., Sikora, J., Mielczarek‐Palacz, A., & Jońca, M. (2005) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2005.04.019 · Cited by 76
Jouvenne, P., Vannier, E. G., Dinarello, C. A., & Miossec, P. (1998) · Arthritis & Rheumatism · doi:10.1002/1529-0131(199806)41:6<1083::aid-art15>3.0.co;2-9 · Cited by 74
Vambutas, A., DeVoti, J. A., Goldofsky, E., Gordon, M., LESSER, M. L., & Bonagura, V. R. (2009) · PLoS ONE · doi:10.1371/journal.pone.0005293 · Cited by 68
RIVIER, C. L. (1994) · Journal of Endocrinology · doi:10.1677/joe.0.1400365 · Cited by 66
Orlando, S., Matteucci, C., Fadlon, E., et al. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.158.8.3861 · Cited by 58
Akoum, A., Lawson, C., Herrmann-Lavoie, C., & Maheux, R. (2007) · Human Reproduction · doi:10.1093/humrep/dem021 · Cited by 45
Acute Hypoxia Activates the Neuroimmune System, Which Diabetes Exacerbates
Johnson, D. R., O’Connor, J. C., Hartman, M. E., Tapping, R. I., & Freund, G. G. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4560-06.2007 · Cited by 44
Self-citationDecreased Expression of the Decoy Interleukin-1 Receptor Type II in Human Endometriosis
Akoum, A., Jolicoeur, C., Kharfi, A., & Aubé, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63990-9 · Cited by 44
Gabellec, M., Griffais, R., Fillion, G., & Haour, F. (1996) · Journal of Neuroimmunology · doi:10.1016/0165-5728(96)00021-5 · Cited by 43
Wang, X., Romanic, A. M., Yue, T., et al. (2000) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2000.2588 · Cited by 40
Stahl, N., Radin, A. R., & Mellis, S. J. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.05074.x · Cited by 40
Dawson, J., Engelhardt, P., Kastelic, T., Cheneval, D., MacKenzie, A. R., & Ramage, P. (1999) · Lara D. Veeken · doi:10.1093/rheumatology/38.5.401 · Cited by 39
Spriggs, M. K., Nevens, P. J., Grabstein, K. H., et al. (1992) · Cytokine · doi:10.1016/1043-4666(92)90042-p · Cited by 35
Pou, J., Martínez‐González, J., Rebollo, A., Rodrı́guez, C., Rodríguez‐Calvo, R., Martín‐Fuentes, P., Cenarro, A., Civeira, F., Laguna, J. C., & Alegret, M. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2011.05.014 · Cited by 33
Simeoni, E., Dudler, J., Fleury, S., Li, J., Pagnotta, M., Pascual, M. A., von Segesser, . K., & Vassalli, G. (2006) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2006.10.042 · Cited by 30
Herman, A. P., Misztal, T., Herman, A., & Tomaszewska-Zaremba, D. (2010) · Reproduction in Domestic Animals · doi:10.1111/j.1439-0531.2010.01595.x · Cited by 29
Yan, B., Chen, G., Saigal, K., Yang, X., Jensen, S. T., Waes, C. V., Stoeckert, C. J., & Chen, Z. (2008) · Genome biology · doi:10.1186/gb-2008-9-3-r53 · Cited by 29
Chun, S., Kim, H., Ku, S., Suh, C. S., Kim, S. H., & Kim, J. G. (2012) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2012.01136.x · Cited by 27
Soluble Human IL-1 Receptor Type 2 Inhibits Ectopic Endometrial Tissue Implantation and Growth
Khoufache, K., Bondza, P. K., Harir, N., Daris, M., Lebœuf, M., Mailloux, J. R., Lemyre, M., Foster, W. G., & Akoum, A. (2012) · American Journal Of Pathology · doi:10.1016/j.ajpath.2012.06.022 · Cited by 25
IL-1 modulation of cytokine receptors on bone marrow cells. In vitro and in vivo studies
Shieh, J.-H., Peterson, R. H. F., & Moore, M. A. (1991) · The Journal of Immunology · doi:10.4049/jimmunol.147.4.1273 · Cited by 25
Bristulf, J., & Bartfai, T. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(95)11336-u · Cited by 25
Blockade of brain type II interleukin-1 receptors potentiates IL1β-induced anorexia in mice
Cremona, S., Layé, S., Dantzer, R., & Parnet, P. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00238-9 · Cited by 25
Assessment of human stress and depression by DNA microarray analysis
Ohmori, T., Morita, K., Saito, T., Ohta, M., Ueno, S., & Rokutan, K. (2005) · The Journal of Medical Investigation · doi:10.2152/jmi.52.266 · Cited by 24
Kharfi, A., & Akoum, A. (2002) · Fertility and Sterility · doi:10.1016/s0015-0282(02)03335-6 · Cited by 21
Lukiw, W. J., Martı́nez, J., Peláez, R. P., & Bazan, N. G. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8630 · Cited by 15
Sambo, P., Fadlon, E., Sironi, M., et al. (1996) · Blood · doi:10.1182/blood.v87.5.1682.1682 · Cited by 14
Tedgui, A., Ait‐Oufella, H., & Mallat, Z. (2010) · Atherosclerosis · doi:10.1002/9783527629589.ch4 · Cited by 6
Bischof, A. (2000) · doi:10.1002/1521-4141(200003)30:3
Cited by
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Bent, R., Moll, L., Grabbe, S., & Bros, M. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082155 · Cited by 444
The family of the interleukin‐1 receptors
Boraschi, D., Italiani, P., Weil, S., & Martin, M. U. (2018) · Immunological Reviews · doi:10.1111/imr.12606 · Cited by 389
Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
Iwaszko, M., Biały, S., & Bogunia-Kubik, K. (2021) · Cells · doi:10.3390/cells10113000 · Cited by 311
Busslinger, G. A., Weusten, B. L. A., Bogte, A., Begthel, H., Brosens, L. A. A., & Clevers, H. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.108819 · Cited by 282
The interleukin-1 receptor family
Boraschi, D., & Tagliabue, A. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.10.023 · Cited by 227
Metadata
- Authors
- Peters, V. A., Joesting, J. J., & Freund, G. G.
- Venue
- Brain, Behavior, and Immunity
- Publisher
- Elsevier BV
- Published
- 2013-08
- Volume
- 32
- Pages
- 1-8
- ISSN
- 0889-1591 (ISSN-L)
- OpenAlex
- W2031721046
- Cited by
- 264
- References
- 88
- FWCI
- 2.70
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.